NSE - Delayed Quote INR

Lincoln Pharmaceuticals Limited (LINCOLN.NS)

Compare
803.90
-3.80
(-0.47%)
At close: January 10 at 3:29:28 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
7,002,904.00
5,874,202.00
5,343,572.00
4,523,592.00
Total Liabilities Net Minority Interest
1,074,545.00
849,458.00
1,014,798.00
859,669.00
Total Equity Gross Minority Interest
5,928,359.00
5,024,744.00
4,328,774.00
3,663,923.00
Total Capitalization
5,928,359.00
5,024,744.00
4,328,774.00
3,665,368.00
Common Stock Equity
5,928,359.00
5,024,744.00
4,328,774.00
3,663,923.00
Net Tangible Assets
5,925,099.00
5,021,798.00
4,324,947.00
3,659,943.00
Working Capital
3,544,631.00
2,950,676.00
2,623,635.00
2,329,103.00
Invested Capital
5,939,027.00
5,044,716.00
4,349,210.00
3,669,120.00
Tangible Book Value
5,925,099.00
5,021,798.00
4,324,947.00
3,659,943.00
Total Debt
10,668.00
19,972.00
20,436.00
5,197.00
Share Issued
20,029.73
20,029.73
20,029.73
20,000.00
Ordinary Shares Number
20,029.73
20,029.73
20,029.73
20,000.00
3/31/2021 - 12/17/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers